Financial insights of PRAX

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Collaboration revenue	0	0	-	302
Research and development	65,797	63,006	60,806	41,881
General and administrative	12,562	13,061	13,922	15,256
Total operating expenses	78,359	76,067	74,728	57,137
Loss from operations	-78,359	-76,067	-74,728	-56,835
Other income, net	4,425	4,940	5,432	4,925
Total other income	4,425	4,940	5,432	4,925
Net loss	-73,934	-71,127	-69,296	-51,910

Net loss per share attributable to common stockholders, basic (in dollars per share)	-3.36	-3.31	-3.29	-2.75
Net loss per share attributable to common stockholders, diluted (in dollars per share)	-3.36	-3.31	-3.29	-2.75
Weighted average common shares outstanding, basic (in shares)	21,977,268	21,474,827	21,055,834	18,884,562
Weighted average common shares outstanding, diluted (in shares)	21,977,268	21,474,827	21,055,834	18,884,562